The new-generation, high-energy, 595 nm, long pulse-duration, pulsed-dye laser effectively removes spider veins of the lower extremity

被引:20
作者
Bernstein, Eric F.
机构
[1] Laser Surg Ctr, Bryn Mawr, PA 19010 USA
[2] Cosmet Dermatol Ctr, Bryn Mawr, PA 19010 USA
关键词
laser; pulsed-dye; spider vein; leg;
D O I
10.1002/lsm.20413
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Objectives: Lower-extremity spider veins are a cosmetic problem that poses formidable clinical difficulty for laser removal. They are significantly harder to remove than facial telangiectasias. A new-generation, pulsed-dye laser (PDL), capable of administering pulses that clinically behave like true 40-millisecond pulses has been developed, by doubling the number of sub-pulses comprising each laser pulse. Study Design/Materials and Methods: Fifteen subjects with Fitzpatrick skin types I-III were enrolled in the study and treated to 35 sites. Subjects were treated three times at 2 6-week intervals using an average fluence of 20.4 J/cm(2), a 3 x 10 mm spot, and a dynamic cooling device to protect the epidermis. Digital photographs were taken before initiating treatment and 8 weeks following the final treatment. Results: Mean improvement scores using a 4-point scale as rated subjectively by the treating physician were 0.92 (< 25%), 2.7 (similar to 40-50%), and 3.6 (similar to 65-75%), 6 weeks following 1st and 2nd treatments and 8 weeks following the 3rd and final treatment, respectively. Improvement was also determined by three physicians, rating digital photographs and blinded as to which photographs were pre- or post-treatment. They rated improvement as mild (0-25%) in 10.5% of photographs, moderate (26-50%) in 15.2%, marked (51-75%) in 38.1%, and excellent (76-100%) in 6.3%. There was no textural change in any treatment site. Conclusions: The new-generation, high-energy, 595 nm, long pulse-duration, PDL effectively removes lower-extremity spider veins in subjects with skin types I-III.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 20 条
[1]   SELECTIVE PHOTOTHERMOLYSIS - PRECISE MICROSURGERY BY SELECTIVE ABSORPTION OF PULSED RADIATION [J].
ANDERSON, RR ;
PARRISH, JA .
SCIENCE, 1983, 220 (4596) :524-527
[2]   Treatment of spider veins using a 10 millisecond pulse-duration frequency-doubled neodymium YAG laser [J].
Bernstein, EF ;
Kornbluth, S ;
Brown, DB ;
Black, J .
DERMATOLOGIC SURGERY, 1999, 25 (04) :316-320
[3]   Treatment of spider veins with the 595 nm pulsed-dye laser [J].
Bernstein, EF ;
Lee, J ;
Lowery, J ;
Brown, DB ;
Geronemus, R ;
Lask, G ;
Hsia, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (05) :746-750
[4]   Clinical characteristics of 500 consecutive patients presenting for laser removal of lower extremity spider veins [J].
Bernstein, EF .
DERMATOLOGIC SURGERY, 2001, 27 (01) :31-33
[5]   DETERMINATION OF INCIDENCE AND RISK-FACTORS FOR POSTSCLEROTHERAPY TELANGIECTATIC MATTING OF THE LOWER-EXTREMITY - A RETROSPECTIVE ANALYSIS [J].
DAVIS, LT ;
DUFFY, DM .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1990, 16 (04) :327-330
[6]  
Duffy D M, 1988, Adv Dermatol, V3, P221
[7]   TREATMENT OF TELANGIECTASIA - A REVIEW [J].
GOLDMAN, MP ;
BENNETT, RG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (02) :167-182
[8]   CUTANEOUS NECROSIS, TELANGIECTATIC MATTING, AND HYPERPIGMENTATION FOLLOWING SCLEROTHERAPY - ETIOLOGY, PREVENTION, AND TREATMENT [J].
GOLDMAN, MP ;
SADICK, NS ;
WEISS, RA .
DERMATOLOGIC SURGERY, 1995, 21 (01) :19-29
[9]  
GOLDMAN MP, 1995, SCLEROTHERAPY TREATM, P292
[10]  
Hsia J, 1997, LASER SURG MED, V20, P1, DOI 10.1002/(SICI)1096-9101(1997)20:1<1::AID-LSM1>3.0.CO